Soliqua
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Soliqua, covering 2020-01-13 to 2022-04-25. Get the full timeline:
Most recent: Clinical Trial Update: Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM) [Phase 3]